Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 69 publications.

Desai A, Dong OM, Gautier S, Johnson T, Wong A, Osman AMY, Harvey J, Tran TH, Holladay Ford DM, Kerr KW, Aggarwal A, Mauskopf J. A systematic review of health economic evaluations of oral nutritional supplements as a single-component or multi-component intervention in older adults with or at risk of malnutrition. Poster to be given at the ISPOR Europe 2024; November 18, 2024. Barcelona, Spain.

Johannesen K, Herring WL, Chopra R, Elpers B, Dong O. Using patient-level simulation to estimate long-term survival in idiopathic pulmonary fibrosis. Poster to be given at the ISPOR Europe 2024; November 17, 2024. Barcelona, Spain.

Dong OM, Herring W, Chopra P, Elpers B, Johannesen K. A targeted literature review of lung function decline in idiopathic pulmonary fibrosis to improve survival predictions in cost-effectiveness analyses. Poster presented at the ISPOR 2024; May 8, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S148. doi: 10.1016/j.jval.2024.03.2259

Herring WL, Gallagher ME, Shah N, Morse KC, Mladsi D, Dong OM, Chawla A, Leiding JW, Zhang L, Paramore C, Andemariam B. Cost-effectiveness of lovotibeglogene autotemcel (lovo-cel) gene therapy for patients with sickle cell disease and recurrent vaso-occlusive events in the United States. Pharmacoeconomics. 2024 Jun;42(6):693-714. doi: 10.1007/s40273-024-01385-9

Dong O, Manga N, Zhong Y, Zhang Y, Krause T, Griffin J, Herring WL, Wolowacz S. Use of patient-reported outcomes as key drivers in cost-effectiveness models: a review of UK National Institute for Health and Care Excellence health technology assessments. Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S78. doi: 10.1016/j.jval.2023.03.405

Dong O, Purser M, Herring WL, Mladsi DM, Gallagher M, Chawla A, Leiding JW, Andemariam B. Relationships among sickle cell disease complications and their implications for cost-effectiveness modeling for therapies with curative intent. Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S115-6. doi: 10.1016/j.jval.2023.03.611

Dong O. How are genetic tests evaluated for clinical use in the UK? Presented at the Duke Precision Medicine Forum Series; May 11, 2023. Durham, NC.

Dong OM, Friede KA, Chanfreau-Coffinier C, Voora D. Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes. Eur Heart J Qual Care Clin Outcomes. 2023 Apr 26;9(3):249-57. doi: 10.1093/ehjqcco/qcac031

Perugini M, Johnson TJ, Beume TM, Dong OM, Guerino J, Hu H, Kerr K, Kindilien S, Nuijten M, Ofili TU, Taylor M, Wong A, Freijer K. Are we ready for a new approach to comparing coverage and reimbursement policies for medical nutrition in key markets: an ISPOR special interest group report. Value Health. 2022 May;25(5):677-84. doi: 10.1016/j.jval.2022.01.011

Dong OM, Poonnen PJ, Winski D, Reed S, Vashistha V, Bates J, Kelley MJ, Voora D. Cost-effectiveness of tumor genomic profiling to guide first-line targeted therapy selection in patients with metastatic lung adenocarcinoma. Value Health. 2022 Apr;25(4):582-94. doi: 10.1016/j.jval.2021.09.017

Boucher N, Van Voorhees E, Vashi A, Dong O, Morgan P, Smith JE, Adam S, Alishahi A, Mulholland MJ, Dietch JR, Whited JD, Boggan JC, Fulton JJ, Cameron CB, Gordon A, Goldstein KM, Ear B, Williams JW, Cantrell S, Dickerson SW, Gierisch JM. Tele-urgent care for low-acuity conditions: a systematic review. 2022.

Sperber N, Dong O, Roberts M, Dexter P, Elsey A, Ginsburg G, Horowitz C, Johnson J, Levy K, Ong H, Peterson J, Pollin T, Rakhra-Burris TK, Ramos M, Skaar T, Orlando L. How does the eric typology apply to implementation of clinical decision support for genomic medicine?: specifying and reporting implementation strategies for desired outcomes among a genomic medicine implementation network. Presented at the 14th Annual Conference on the Science of Dissemination and Implementation in Health; December 15, 2021.

Dong OM. Using the diffusion of innovation theory to understand the challenges and opportunities to advancing use of nutrigenetics in clinical practice. Lifestyle Genom. 2021 Dec;14(4):124-8. doi: 10.1159/000517760

Dong OM, Roberts MC, Wu RR, Voils CI, Sperber N, Gavin KL, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Chapman JG, Voora D. Evaluation of the veterans affairs pharmacogenomic testing for veterans (PHASER) clinical program at initial test sites. Pharmacogenomics. 2021 Nov 1;22(17):1121-33. doi: 10.2217/pgs-2021-0089

Brunette CA, Dong OM, Vassy JL, Danowski ME, Alexander N, Antwi AA, Christensen KD. A cost–consequence analysis of preemptive SLCO1B1 testing for statin myopathy risk compared to usual care. J Pers Med. 2021 Oct 31;11(11):1123. doi: 10.3390/jpm11111123

Dong OM. Integrating genetic predictors of salt sensitivity into dietetics practice. Presented at the 2021 Virtual Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN); September 26, 2021.

Kohlmeier M, Dong OM, Keathley J, Baah E. Precision nutrition in practice – An ISNN Training Course. Presented at the 2021 Virtual Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN); September 25, 2021.

Sperber NR, Dong OM, Roberts MC, Dexter P, Elsey AR, Ginsburg GS, Horowitz CR, Johnson JA, Levy KD, Ong H, Peterson JF, Pollin TI, Rakhra-Burris T, Ramos MA, Skaar T, Orlando LA. Strategies to integrate genomic medicine into clinical care: evidence from the IGNITE network. J Pers Med. 2021 Jul 8;11(7):647. doi: 10.3390/jpm11070647

Dong OM, Friede K, Chanfreau C, Voora D. One-year cost-effectiveness of CYP2C19- guided de-escalation and escalation of P2Y12 inhibitors in veterans with acute coronary syndromes undergoing percutaneous coronary intervention. Presented at the American College of Cardiology’s Virtual 70th Annual Scientific Session and Exposition; May 15, 2021. [abstract] J Am Coll Cardiol. 2021 May; 77(18 Suppl 1):3416.

Dong OM, Friede KA, Chanfreau-Coffinier C, Voora D. One-year cost-effectiveness of CYP2C19-guided P2Y12 inhibitor de-escalation and escalation in veterans undergoing percutaneous coronary intervention. Presented at the Virtual NHGRI Research Training and Career Development Annual Meeting; April 19, 2021.

Dong OM, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Meyer LJ, Icardi M, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Jacobitz R, Rozelle S, Chapman JG, Voora D. Institutional profile: veterans affairs pharmacogenomic testing for veterans (PHASER) program. Pharmacogenomics. 2021 Jan 6;22(3):2020-0173. doi: 10.2217/pgs-2020-0173

Dong OM, Roberts MC, Wu RR, Reed SD, Voils CI, Chanfreau C, Sperber N, Gavin K, Bates J, Chapman JG, Kelley MJ, Voora D. Association between provider perceptions and ordering of pharmacogenomic tests at veterans affairs Pharmacogenomic Testing for Veterans (PHASER) program test sites. Poster presented at the Virtual American Society of Human Genetics 2020 Annual Meeting; October 27, 2020.

Dong OM, Friede K, Chanfreau C, Voora D. Cost-effectiveness of CYP2C19-guided de-escalation and escalation of P2Y12 inhibitors in veterans undergoing percutaneous coronary intervention. Presented at the PMLS Virtual Series - RTP/Population Health Meeting; October 21, 2020.

Dong OM, Poonnen P. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Presented at the VA Office of National Oncology Virtual Seminar; September 8, 2020. Previously presented at the Duke Center for Applied Genomics and Precision Medicine Forum.

Dong OM. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Presented at the UW Genome Sciences Department Seminar; July 14, 2020. Previously presented at the Duke Center for Applied Genomics and Precision Medicine Forum.

Dong OM. Evaluation of the VA Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. Presented at the 2020 Duke Center for Applied Genomics and Precision Medicine Virtual Forum; June 10, 2020.

Dong OM. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Presented at the Duke Center for Applied Genomics and Precision Medicine Virtual Forum; May 14, 2020.

Dong OM, Roberts MC, Wu R, Reed S, Voils C, Chanfreau C, Sperber N, Gavin K, Bates J, Kelley M, Voora D. A formative evaluation plan for the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Program. Presented at the Virtual NHGRI Research Training and Career Development Annual Meeting; March 31, 2020.

Poonnen P, Dong O, Winski D, Reed SD, Vashistha V, Bates JS, Kelley MJ, Voora D. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Poster presented at the 2020 Virtual American Society of Clinical Oncology Scientific Program Meeting; May 29, 2020. [abstract] J Clin Oncol. 2020; 38(15 Suppl):7075.

Dong O, Wiltshire T. Pharmaconutrigenetics: the impact of genetics on nutrient-drug interactions. In: De Caterina R, Martinez A, Kohlmeier M, editors. Principles of nutrigenetics and nutrigenomics: fundamentals of individualized nutrition. 1st ed. Cambridge: MA. Academic Press; 2020. p.519-24.

Dong O, Wiltshire T. Electrolytes. In: De Caterina R, Martinez A, Kohlmeier M, editors. Principles of nutrigenetics and nutrigenomics: fundamentals of individualized nutrition. 1st ed. Cambridge: MA. Academic Press; 2020. p.309-15.

Dong OM, Wheeler SB, Cruden G, Lee CR, Voora D, Dusetzina SB, Wiltshire T. Cost-effectiveness of multigene pharmacogenetic testing in patients with acute coronary syndrome after percutaneous coronary intervention. Value Health. 2020 Jan 1;23(1):61-73. doi: 10.1016/j.jval.2019.08.002

Suzuki O, Dong OM, Howard RM, Wiltshire T. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing. Pharmacogenomics. 2019 Sep;20(14):1005-20. doi: 10.2217/pgs-2019-0057

Kohlmeier M, Dong OM. Precision nutrition in practice. Presented at the 2019 Congress of the International Society of Nutrigenetics & Nutrigenomics; July 13, 2019. Cambridge, United Kingdom. Previously presented at the 2018 Congress of the International Society of Nutrigenetics & Nutrigenomics.

Dong OM. Using genetic information to personalize nutritional and pharmaceutical interventions for patients with cardiovascular disease. Presented at the North Carolina Council on Renal Nutrition Spring Meeting; March 29, 2019. Mebane, NC.

Cruden G, Spencer J, Dong OM. Improving the identification of adolescent depression through primary care screening approaches. Presented at the 40th Annual Meeting of the Society for Medical Decision Making; October 17, 2018. Montreal, Canada. [abstract] Med Decis Making. 2018 Dec 27; 39(1):E272. doi: 10.1177/0272989X18821191

Frick A, Benton C, Suzuki O, Dong O, Howard R, El-Sabae H, Wiltshire T. Implementing clinical pharmacogenomics in the classroom: student pharmacist impressions of an educational intervention including personal genotyping. Pharmacy (Basel). 2018 Oct 23;6(4):115. doi: 10.3390/pharmacy6040115

Dong OM. Pharmaconutrigenetics in patient care: the impact of genetics on nutrient-drug interactions. Presented at the Congress of the International Society of Nutrigenetics & Nutrigenomics; October 1, 2018. Winnipeg, Canada. Previously presented at the North Carolina Dietetic Association Regional Meeting.

Dong OM, Lee CR, Wheeler S, Voora D, Dusetzina S, Wiltshire T. A cost-effectiveness analysis of multi-gene pharmacogenetic testing in acute coronary syndrome patients following percutaneous coronary intervention. Presented at the 2018 ISPOR 21st Annual European Congress; November 13, 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(Suppl 3):S6.

Kohlmeier M, Dong OM. Precision nutrition in practice. Presented at the Congress of the International Society of Nutrigenetics & Nutrigenomics; September 29, 2018. Winnipeg, Canada.

Dong OM. Excessive dietary sodium intake and elevated blood pressure: a review of current prevention and management strategies and the emerging role of pharmaconutrigenetics. BMJ Nutr Prev Health. 2018 Sep 19;1(1):7-16. doi: 10.1136/bmjnph-2018-000004

Dong OM, Howard RM, Church R, Cottrell M, Forrest A, Innocenti F, Mosedale M, Kashuba A, Gonzalez D, Wiltshire T. Challenges and solutions for future pharmacy practice in the era of precision medicine. Am J Pharm Educ. 2018 Aug;82(6):6652. doi: 10.5688/ajpe6652

Kohlmeier M, Dong O. CKM genetic variants and muscle vulnerability to low magnesium intake. Presented at the 2018 American Society for Nutrition Annual Meeting; June 11, 2018. Boston, MA. [abstract] Curr Dev Nutr. 2018 Jun 28; 2(11). doi: 10.1093/cdn/nzy044

Dong OM. Incorporating pharmacogenetics into patient care. Presented at the Nutrigenetics, Nutrigenomics, and Precision Nutrition Workshop, UNC Nutrition Research Institute; June 7, 2018. Kannapolis, NC.

Dong OM, Li A, Suzuki O, Oni-Orisan A, Gonzalez R, Stouffer GA, Lee CR, Wiltshire T. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients. Pharmacogenomics. 2018 Jun 1;19(9):771-82. doi: 10.2217/pgs-2018-0049

Dong OM. Integrating nutrigenetics into patient care. Presented at the North Carolina Council on Renal Nutrition Spring Meeting; May 31, 2018. Charlotte, NC.

Wiltshire T, Dong OM. Clinical pharmacogenetics: how do we ensure a favorable future for patients? Pharmacogenomics. 2018 Apr;19(6):553-62. doi: 10.2217/pgs-2017-0192

Dong OM, Young L, Wiltshire T, Guenzel N. The prevalence of atypical antipsychotic medication changes based on CYP2D6 genotyping in patients with psychiatric disorders. Poster presented at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting; March 22, 2018. Orlando, FL.

Dong OM. Pharmaconutrigenetics in patient care: the impact of genetics on nutrient-drug interactions. Presented at the Durham-Chapel Hill Dietetic Association Meeting; March 13, 2018. Durham, NC. Previously presented at the North Carolina Dietetic Association Regional Meeting.

Dong OM. Pharmaconutrigenetics in patient care: the impact of genetics on nutrient-drug interactions. Presented at the North Carolina Dietetic Association Regional Meeting; March 2, 2018. Gastonia, NC.